2017-2019 Patronus

The PATRONUS consortium consists of experts in exposure therapy, as well as specialists in hardware and software for data analytics, scalable data processing, VR, mobile and patient-centered services. PATRONUS will offer an effective, lightweight and personalized blended care solution consisting of IT tools that support the therapist and patient throughout the anxiety treatment process. It is capable of:

personalized and objective anxiety assessment based on physiological data from wearables with an accuracy of greater than 90% during exposure therapy; a comprehensive therapist dashboard allowing seamless patient follow-up and (VR) therapy management; a personalized, low-cost and ergonomic VR experience incorporating biofeedback enabling automatic adaptation to the emotions of the patient; individualized longitudinal follow-up and coaching through VR homework exercises and a mobile application.

PATRONUS will also develop clinical protocols for at least 2 phobias (claustrophobia and panic disorders) on effective exposure therapy and follow-up using the solution.

Read more concerning this project on the imec website.

2017-2018 Learn2Act

Acceptance and Commitment Therapy is being offered in a blended manner by the Belgian organisation Learn2Act. Our expertise unit is currently providing input on how this app can possibly be used as a tool for relapse prevention, following a successful treatment. The main focus is on how the app and its use can function as a screening tool to detect potential downward spirals.

2016 – 2021 eMEN

Each year almost 165 million, or 38%, of people in the EU experience a mental health condition such as depression or anxiety. Mental ill health presents a huge and growing economic and social burden for society, accounting for 20% of the disease burden.

Innovative and high-quality e-mental health plays an important role in tackling this societal challenge. However, due to specific challenges, there are large regional differences with regard to the use of e-mental health products, for prevention and treatment.

The average use across the Netherlands, France, Germany, UK, Belgium and Ireland is now 8%, which is low compared to other healthcare sectors; with the lowest use in FR (less than 1%) and the highest in the Netherlands (15%). Unmet needs are also high, with an EU average of 6.8%. At the end of the project, the average use of e-mental health products will have increased by 7%, to 15%. This directly contributes to the region’s economic performance and innovation capacity: reducing healthcare costs, better care and access to prevention and treatment and increased growth of eHealth SMEs.

In order to realise this change, a first-of-its-kind, EU-wide platform for e-mental health innovation and implementation will be formed by private and public partners in North West Europe. Project partners are key stakeholders in the field of e-mental health and have a broad EU network.

Read more on the eMEN-website.

2015 – 2019 Carewear

The goal of the Carewear project is to improve current practice of organisations which are active in the field of wellbeing at work and mental healthcare. It aims to achieve this goal by implementing wearable technology. During the project, two intervention programs will be developed for wearables making use of (amongst other) skin conductance and heart rate variability. We hereby focus on burn-out prevention as our main intervention target in a corporate context and on the treatment of depression as an exploratory goal in the context of mental health care.

Read more on the Carewear website.

2015 – present

We regularly explore new and innovative medication packaging designs, together with LiCalab. In the past, we relied on partners from other EU-countries like The United Kingdom, Denmark and Germany, partners from Asia and Oceania (Australia, China and Japan) and Latin and South-America (Brazil, Colombia and Mexico). The contribution of PsyTS mainly consisted of the design and running of research protocols for human factor studies and customer experience studies.

Read more about a previous study on the LiCalab website.